Covid-19 India update: Bottlenecks in raw materials supply unlikely to impact vaccine production, says Serum Institute
Serum Institute is manufacturing Oxford-AstraZeneca’s vaccine under the brand name Covishield. Coronavirus vaccine in India: The bottlenecks that are present in the supply of some raw materials required for the production of COVID-19 vaccines are unlikely to impact the production of doses at the Pune-based Serum Institute of India in the immediate future, according to … Read more